P. Seibold

P. Seibold is a researcher at the German Cancer Research Center (DKFZ) specializing in radiation oncology with a focus on prostate cancer treatment and screening. Their work primarily involves studying dose-response relationships in radiotherapy, toxicity prediction, and screening protocols for prostate cancer.

Seibold's research interests center on optimizing radiotherapy for prostate cancer patients, with particular emphasis on understanding and predicting treatment-related toxicities. Their work bridges radiation oncology, radiogenomics, and cancer screening methodologies, focusing on improving patient outcomes through precision medicine approaches.

Recent publications demonstrate a strong focus on the PROBASE trial, investigating prostate cancer screening strategies for younger men and evaluating optimal diagnostic approaches. Their research on dose-response mapping and polygenic risk scores for radiation toxicity represents cutting-edge work in personalized radiation oncology.

Seibold collaborates extensively with urologists, radiation oncologists, and epidemiologists across multiple institutions, contributing to significant advancements in prostate cancer management protocols.